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A competitive enzyme-linked aptamer assay (ELAA) to detect tetracycline in milk was performed by using two diﬀerent aptamers
individually; one is 76 mer-DNA aptamer and the other is 57 mer-RNA aptamer. The best optimum condition was obtained
without monovalent ion, Na+ and also by adding no Mg2+ ion in the assay buﬀer, along with RT incubation. The optimized ELAA
showed a good sensitivity (LOD of 2.10 × 10−8 M) with a wide dynamic range (3.16 × 10−8 M ∼ 3.16 × 10−4 M). In addition,
the average R.S.D. across all data points of the curve was less than 2.5% with good recoveries (∼101.8%) from the milk media.
Thus, this method provides a good tool to monitor tetracycline in milk from MRLs’ point of view. However, this ELAA method
was not superior to the ELISA method in terms of speciﬁcity. This paper describes that it does not always give better sensitivity
and speciﬁcity in assays even though aptamers have several advantages over antibodies and have been known to be good binders
for binding assays.
1.Introduction
Aptamer-based biosensing system has been widely investi-
gated and developed to detect various proteins, small chemi-
cals, and metabolites such as nucleic acids and carbohydrates
in biological, environmental substance and food products
[1–11]. Aptamers are functional oligonucleotides of single-
stranded DNA or RNA which can recognize and bind to
the speciﬁc target molecules with high aﬃnity, speciﬁcity,
and selectivity. As biomolecular recognizers, aptamers are
usedfordiagnosticandtherapeuticapplications.Duetotheir
small size, aptamers might be able to reduce steric hindrance
and approach analytes more easily. Suitable aptamers can
be selected by in vitro selection process called SELEX
(systematic evolution of ligands by exponential enrichment)
[2, 3] and generated in the short term compared with
antibodies.
Tetracyclines (TCs) are a group of broad-spectrum anti-
bacterialagent.Thesehavebeenwidelyusedtotreatbacterial
infections in both humans and animals and to promote
growth rate for animals. TCs are used in pure or mixed form
with derivatives, oxytetracycline (OTC), chlortetracycline
(CTC), and doxycycline (DC) (Figure 1)[ 12]. Therefore,
food products from medicated animals such as meat [13],
milk [14–16], ﬁsh [17, 18], and eggs [18]m a yc o n t a i n
TC residues and may cause serious health problems in
people who take these food. According to the Codex MRLs
(maximum residue levels) database, the MRLs of TCs are
100μg/kginmilk,200μg/kginmuscle,600μg/kginliver,and
1200μg/kg in kidney (cattle).
Several methods have been reported for the detection of
TCs using a variety of techniques, such as high-performance
liquidchromatography(HPLC)andliquidchromatography-
tandem mass spectrometry (LC-ESI-MS/MS) [19, 20]. These
instrumental analyses provide simultaneous and accurate
detection of TCs, including basic TC, OTC, DC, and 4-
epitetracycline. However, these methods require expensive
instruments and sample extraction and cleanup. There is
a need for fast, easy to use, and cost-eﬀective analytical
methods. Indeed, well-established immunoassay techniques
were developed to meet these requirements [21–23].
Recently, enzyme-linked immunosorbent assays were
performed for determination of TC in food. These assays
provide speciﬁcity, high sensitivity with less than 0.4μg/L2 The Scientiﬁc World Journal
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Figure 1: General structure of TCs.
of detection limit, and broad dynamic range that enable
to detect target molecules [21–23]. Although the ability
of antibodies to bind to their target is remarkable, there
are some drawbacks, including a complicated process for
antibody production and stability under elevated temper-
atures. By comparison, aptamers have several advantages.
They are highly chemically stable over a wide temperature
range, have reversible denaturation, and can be isolated by in
vitromethodswithoutimmuneresponse.Thus,aptamersare
synthesized rapidly. DNA aptamer can be obtained in just a
few days. Furthermore, they are easy to modify and label. A
site-speciﬁc modiﬁcation techniques are developed to attach
various molecules such as biotin groups [9], thiol groups
[24], and label molecules [8]a t3   or 5  end of aptamer
without aﬀecting the target binding site and can make one-
to-oneconjugate(aptamer:label)likegene-fusiontechnique
[25–27].
TC has several binding aptamers, including 76 mer-DNA
aptamer and 57 mer-RNA aptamer [12, 28]. 76 mer-DNA
aptamer has high aﬃnities for the basic TC backbone and
has a dissociation constant (Kd)o f6 3 n M[ 26, 27]. An
electrochemical aptasensor has been studied utilizing this
DNA aptamer [29, 30]. RNA aptamer can fold and form
binding pocket to accommodate TC. It also binds to TCs
tightly with a Kd of 770pM, as determined by ﬂuorimetry
[28]. TC is a ﬂat polycyclic molecule and has one aromatic
ring. One face of the molecule makes ionic interaction with
a part of RNA residues, while the other face associates
with another part by multiple stacking or hydrophobic
interactions[28,31].Severalreportssuggestthatmagnesium
ions are also essential for TC binding, because RNA aptamer
recognizesthismetalionthatcoordinatestheTC[28,31–33].
To stabilize the conformation of aptamer, monovalent
c a t i o n ss u c ha sL i +,N a +,a n dK + have been used in aptamer
assays as well as divalent ions. In some thrombin aptasensor
studies, the eﬀectsof these cations were validated by addition
of Na+ or K+ which can stabilize G-quadruplex structure
and reduce nonspeciﬁc binding [34, 35]. However, Na+ or
K+ is able to interact with negatively charged phosphate
backbone of the aptamer and form weak complexes at higher
concentration of cations [34]. Thus, they may lead to the
conformational changes of binding site and cause aptamer’s
lower aﬃnity to their target.
In this work, we establish a competitive enzyme-linked
aptamer assay (ELAA) based on both DNA and RNA
aptamers as recognition elements to determine residues of
TC in milk samples. The biotinylated-aptamer was immobi-
lizedontomicroplateviaavidin-biotininteraction.Although
the aptamers are known as binders with low nanomolar Kd
values and exceptional recognition ability like antibodies, the
speciﬁcity of aptamer has not been veriﬁed as well as that of
antibodies. Also, we report that aptamers can measure the
amount of TCs with maximum accuracy and provide the
assay sensitivity (LOD) and % recovery rates in milk matrix.
2.MaterialsandMethods
2.1. Reagents. A single-stranded DNA aptamer was pur-
chased from Genotech (Daejeon, Korea) and had the follow-
ing sequences: 76 mer, 5 -CGT ACG GAA TTC GCT AGC
CCC CCG GCA GGC CAC GGC TTG GGT TGG TCC CAC
TGCGCGTGGATCCGAGCTCCACGTG-3 -biotin(Mw.
(23746.2), mp (88.8◦C)). The DNA aptamer was modiﬁed
through 3 -end biotin modiﬁcation using biotin-triethylene
glycol (TEG).
An RNA aptamer was synthesized with a DMT- (di-
methoxytrityl-) Biotin amidite at the 5  end by ST Pharm
(Seoul, Korea). The sequences are shown as the following: 57
mer, biotin-5 -GAG CCU AAA ACA UAC CAG AGA AAU
CUG GAG AGG UGA AGA AUA CGA CCA CCU AGG
CUC-3  (Mw. (18869.7), mp (86.8◦C)).
Hydrochlorides of TC, OTC, CTC, and DC were pur-
chased from Sigma (St. Louis, Mo, USA). Neutravidin
was obtained from Pierce (Rockford, Ill, USA). Bovine ser
xum albumin (BSA), ovalbumin (OVA), trichloroacetic acid
(TCA), Na2EDTA, 3,3 ,5,5 -tetramethylbenzidine dihydro-
chloride (TMB), and phosphate-citrate buﬀer with sodium
perborate were supplied from sigma (St. Louis, Mo, USA).
Sodium bicarbonate, sodium carbonate, sodium phosphate
monobasic, sodium phosphate dibasic, citric acid monohy-
drate, and sodium chloride were purchased from Duksan
Pure Chemical (Ansan, Kyunggido, Korea). McIlvain buﬀer
solution was prepared by dissolving 11.8g of citric acid
monohydrate, 13.72g of Na2HPO4, and 33.62g of Na2EDTA
in one liter of distilled water [21]. All chemicals were of
analytical grade, and triply deionized water (Milli-Q water
puriﬁcation system, Millipore, Billerica, Mass, USA) was
used. All buﬀers were ﬁltered using 0.20μm membrane ﬁlter
system.
2.2. Instrumentation. ELAA was performed in Flat-bot-
tomed polystyrene immuno plates (Nunc, Denmark). En-
zyme activity was detected using E-max microtiter plateThe Scientiﬁc World Journal 3
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Figure 2: Optimization of TC assay conditions. (a) The concentration of DNA aptamer was (•) 0.0250μgmL −1,( ◦) 0.0188μgmL −1,a n d
() 0.0125μgmL −1 and the concentration of TC-HRP conjugate was 1μgmL −1 in a solid line and 0.5μgmL −1 in a dotted line. (b) Eﬀect of
incubation temperature on ELAA performance: (•)r o o mt e m p e r a t u r ea n d( ◦)4 ◦C. (c) Inﬂuence of thermal denaturation of DNA aptamer:
(•)9 5 ◦C, 10min and (◦) no treatment.
reader (Molecular Device Co., Sunnyvale, Calif, USA) at
450nm. Microplates were washed using Multiwasher III
(Tricontinent, Grass valley, Calif, USA). Centrifugation was
performed in Supra22K from Hanil Sci. (Incheon, Korea).
2.3. Optimization of Assay Conditions. Prior to the DNA
aptamer assay, the optimization was carried out by varying
concentrations of aptamer and TC-HRP because the assay
sensitivity is dependent on the concentrations of binder and
competitor. The DNA aptamer was diluted to 0.025μgmL −1,
0.0188μgmL −1, and 0.0125μgmL −1. The TC-HRP conju-
gates were prepared in a concentration of 1μgmL −1 and
0.5μgmL −1. The optimization of amount of neutravidin
was also performed in three diﬀerent concentrations of
1μgmL −1,0 . 5 μgmL −1,a n d0 . 1 μgmL −1. The incubation
temperature was examined by incubating DNA aptamer,
standard TC solution, and TC-HRP at 4◦C or RT, respec-
tively. The assay was conducted with the aptamer with and4 The Scientiﬁc World Journal
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Figure 3: Dose-response curve and calibration curve (inset) for TC
inbuﬀer. % B/B0 =−30.3121×log [TC]−104.0775, R2 = 0.9934.
Data points are the average plus ± one standard deviation (n = 3).
without a thermal treatment before immobilization, and
the results were compared. The thermal denaturation was
performed by heating the aptamer at 95◦Cf o r1 0m i na n d
then cooling it rapidly in ice.
In the RNA aptamer assay, it was performed for opti-
mization of operating conditions. The incubation tem-
perature was also examined by incubating at 4◦Co rR T .
Several buﬀers were compared as diluents for all materials,
including 10mM phosphate, PBS, and phosphate containing
2.5mMand5mMMg 2+. To optimize the concentration of
aptamer, the RNA aptamer solution was diluted as ranging
from 0.02μgmL −1 to 0.1μgmL −1 in 10mM phosphate
buﬀer.
2.4. Enzyme-Linked Aptamer Assay for TC. Neutravidin was
diluted to 1μgmL −1 in coating buﬀer (50mM bicarbonate
buﬀer, pH 9.6), and 100μL was added to wells. The plate
was stored with constant shaking at 4◦Cf o r1 6h .T or e m o v e
unbound neutravidin, wells were washed three times with
300μLwell −1 of the wash buﬀer, PBS-T (10mM PBS, pH
7.2, 0.05% Tween-20). The plate was then blocked with
300μLwell −1 of blocking agents (3% bovine serum albumin
(BSA) or 1% ovalbumin (OVA)) in 10mM phosphate
buﬀer for 30min at RT, and unbound BSA was removed.
Subsequently, 100μL of the biotinylated DNA aptamer
(0.0188μgmL −1)orRN Aaptamer(0.07μgmL −1)wasadded
to each well, respectively, and binding was allowed for 1h
at RT. The unbound materials were removed by washing
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Figure 4: Cross-reactivity study with DNA aptamer for cross-
reactants: (•)T C ,( ◦)O T C ,( ) CTC, and ( ) DC. Data points
are means of triplicate measurements.
three times with the wash buﬀer (10mM PBS-T). TC was
diluted to 2 × 10−3 M–2 × 10−12 M in assay buﬀer (10mM
phosphate, pH 7.2). Each 50μL of various concentrations
of TC solution was added in triplicate, and the plate
was incubated at RT for 30min. Then, 50μL TC-HRP
(1μgmL −1) in assay buﬀer was added to the plate. An
incubation step was accomplished for 30min with constant
shaking at RT. After washing, 100μLo fT M Bi ns u b s t r a t e
buﬀer (50mM phosphate-citrate buﬀer, pH 5.0) was added
and incubated for 10min at RT. The color of solution
changed from colorless to blue. The color reaction was
stopped by adding 50μLo fH 2SO4 (2M). Then, absorbance
was read at 450nm.
2.5. Cross-Reactivity Study. The cross-reactivity study was
performed in the same way as the TC assay. OTC, CTC,
and DC were used as cross-reactants. These are antibacterial
agents with structure related to TC.
2.6.PretreatmentforMilkAssay. TCwasspikedinmilk.Milk
contains protein, fat, carbohydrate, and cations such as Ca2+
and Mg2+ which can form chelation complexes with TC.
To remove these inhabitants, 1mL of milk sample in which
TC spiked in advance was mixed with 4mL of McIlvaine
buﬀer contained 0.02M EDTA (pH 4.0) and 0.4mL of
trichloroaceticacidwasaddedtothismixture.Then,themilk
sample was defatted and deproteinized by centrifugation at
4◦C (5000rpm, 20min). 1M NaOH was added dropwise to
the supernatant to adjust to pH 7.2. The supernatant (5 ×
10−3 M TC in milk sample) was prepared and serially diluted
with treated milk sample (1:19 dilution, milk:phosphate
buﬀer) in concentration ranging from 2 × 10−3 Mt o2×
10−12 M.The Scientiﬁc World Journal 5
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Figure 5:(a)Dose-responsecurveandcalibrationcurve(inset)forTCinmilk.% B/B0 =−27.7749 × log [TC]−82.1902, R2 = 0.9881.(b)
Correlation diagram of B/B0 for TC both in buﬀer and in milk. % B/B0 (in milk) = 0.9550 × % B/B0 (in buﬀer) −10.4243, R2 = 0.9881.
2.7.RecoveriesofTCfromSpikedMilkSamples. FreeTC(9.60
mgL−1,2 . 4 0m gL −1,0 . 4 8m gL −1,0 . 2 5m gL −1,0 . 1 0m gL −1,
and0.05mgL−1)wasspikedinmilk,intenreplicatesamples.
3. Results andDiscussion
The TC aptamer assay was performed by using two diﬀerent
aptamers individually; one is 76 mer-DNA aptamer and the
other is 57 mer-RNA aptamer. The both aptamers has been
known to have high aﬃnities with a dissociation constant
(Kd)of63nMforDNAaptamer(76mer)and770pMfor
RNA aptamer (57mer). A competitive assay with sequential
mode was adapted for both aptamer assays.
3.1. DNA Aptamer (76Mer) Assay. The assay sensitivity
for competitive assays depends on both the immobilized
aptamer concentration on the solid surface and the lim-
ited concentration of the competitor, TC-HRP conjugate.
Thus,theconcentrationsofaptamer(0.0250μgmL −1,0.0188
μgmL −1, and 0.0125μgmL −1) and the competitor, TC-
HRP conjugate (1μgmL −1 and 0.5μgmL −1), are controlled
to optimize the assay performance. Figure 2(a) shows the
binder dilution curve obtained by a matrix combination of
both chosen reagents. The best detection limit was observed
using a combination of 0.0188μgmL −1 of aptamer and
1μgmL −1 of TC-HRP. When 0.5μgmL −1 of the competitor,
TC-HRP conjugate, was used with the same concentration of
aptamer,thesignaldiﬀerencebetweenthehighandlowdoses
of TC was too small (less than 0.1Abs.) to be useful. This is
shown in dotted line.
The eﬀect of incubation temperature in the TC aptamer
assay was examined by incubating aptamer at 4◦Co ra tR T
for 1h each. As shown in Figure 2(b), the assay at 4◦C shows
the worse assay sensitivity with a small signal diﬀerence
compared to that at RT. This result is diﬀerent from the
one obtained from dopamine RNA aptamer assay [9], in
which the tertiary structure of DA aptamer is stable at lower
temperature. Hereafter, experiments were performed at RT.
Additionally, an assay optimization was performed with
the aptamer solution with and without a thermal treatment
before its immobilization (Figure 2(c)). A thermal treatment
of this biotinylated aptamer before the immobilization is
applied to unfold the aptamer strand and also make the
biotin label available for interaction with neutravidin on
the solid support, plates. Thermal treatment involved the
incubation of the aptamer solution at 90◦C for 10min,
followed by rapid cooling in ice for 10min to block the
aptamerinitsunfoldedstructure.Theresultswerecompared
in terms of the TC binding. As shown in Figure 2(c), the
aptamer denaturation did not show any improvement of the
assay eﬃciency. This suggests that the TC aptamer holds the
same folding structures even after the denaturation.
Figure 3 shows the dose-response curve constructed
with the optimized conditions using 0.0188μgmL −1 (7.5
× 10−10 M) of aptamer and 1.0μgmL −1 (1.5 × 10−8 M)
of TC-HRP conjugate in assay buﬀer. The LOD of 3.27 ×
10−8 M (15.7μgmL −1) and the dynamic range of from 1.00
× 10−4 Mt o1 . 9 9× 10−7 M were obtained. The LOD is
deﬁned as the concentration corresponding to 3 standard
deviations below the mean from the blank. The average
relative standard deviation (R.S.D.) across all data points
of the curve was 1.6%. The calibration curve (inset) was6 The Scientiﬁc World Journal
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Figure 6:OptimizationofassayconditionswithRNAaptamer.(a)InﬂuenceoftheadditionofNa+ iononassaybuﬀer;(•)10mMphosphate
buﬀer and (◦)P B Sb u ﬀer (150mM NaCl). (b) Eﬀect of the addition of Mg2+ i o no na s s a yb u ﬀer. The concentration of MgCl2 was (•)n o
addition, (◦) 2.5mM, and () 5mM. (c) Optimization of temperature on the ELAA performance: (•)r o o mt e m p e r a t u r ea n d( ◦)4 ◦C.
constructedonadynamicrange,andleast-squaresregression
[25] of these data gave the following relationship:
%
B
B0
=−30.3121 ×log [TC]
−104.0775,

R2 = 0.9934

.
(1)
In an aptamer assay, the ability of an aptamer to yield
a measurable response selectively for the target molecule is
described as speciﬁcity [12]. The speciﬁcity of the aptamer
was evaluated by cross-reactivity study using three struc-
turally similar compounds, cross-reactants, such as OTC,
CTC, and DC. Cross-reactivity studies were carried out by
a competitive ELAA by adding various free cross-reactants
at diﬀerent concentrations to compete with competitor, TC-
HRP, to bind with the aptamer coated on the surface. Their
50% B/B0 values were estimated and then their percent
cross-reactivity was calculated: % cross-reactivity = (con-
centration of TC giving 50% B/B0)/(concentration of cross-
reactant giving 50% B/B0). B/B0 is the ratio of response B,
to the maximum response when no analyte is present B0.The Scientiﬁc World Journal 7
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(•)0 . 1μgmL −1,( ◦)0 . 0 7μgmL −1,( )0 . 0 5μgmL −1, and ( )0 . 0 2
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Figure 8: Dose-response curve and calibration curve (inset) for TC
in buﬀer. % B/B0 =−23.1788 ×log [TC] −75.2471, R2 = 0.9851.
Data points are the average plus ± one standard deviation (n = 3).
The 50%B/B0 value and cross-reactivity for each compound
are given in Figure 4 and Table 1. These results demonstrated
that OTC showed very high cross-reactivity (129.7%) and
CTC and DC showed relatively high cross-reactivity with
32.4% and 17.5%, respectively. Table 1 lists the comparison
of cross-reactivity, and TC DNA aptamer assay shows no
superior speciﬁcity of the binder as compared to the TC
antibody assay [21].
Table 1: Cross-reactivity (%) of cross-reactants.
Reactants
Cross-reactivity (%)
DNA
aptamer RNA aptamer Antibody
[21]
Tetracycline (TC) 100 100 100
Oxytetracycline (OTC) 129.7 35.3 10
Chlortetracycline (CTC) 32.4 35.3 13.7
Doxycycline (DC) 17.5 30.4 —
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Figure 9: Cross-reactivity study with RNA aptamer for cross-
reactants: (•)T C ,( ◦)O T C ,( ) CTC, and ( ) DC. Data points
are means of triplicate measurements.
Milk samples were obtained from local markets and
stored in refrigerator before use. The protein and fat in milk
sample have an inclination for forming chelating complexes
with divalent ions, and they cause a matrix eﬀect. To
remove these interferences, the milk sample was treated with
McIlvaine-EDTA buﬀer to block any interaction with TC
and divalent cations. And then 20% trichloroacetic acid was
used for denaturation of milk protein. The dose-response
curve was performed using 0.0188μgmL −1 (7.5 × 10−10 M)
of aptamer and 1.0μgmL −1 (1.5 × 10−8 M) of TC-HRP
conjugate. Figure 5(a) shows the dose-response curve and
calibration curve for TC in milk. The LOD and the dynamic
r a n g ew e r e9 . 5 2× 10−8 M (45.7μgmL −1) and from 3.16 ×
10−4 Mt o3 . 1 6× 10−7 M, respectively:
%
B
B0
=−27.7749 ×log [TC]
−82.1902,

R2 = 0.9881

.
(2)
Figure 5(b) shows the correlation diagram of the absorbance
obtained both in buﬀer and in milk:
%
B
B0
(in milk) = 0.9550 ×%
B
B0
(in buﬀer)
−10.4243,

R2 = 0.9881

.
(3)8 The Scientiﬁc World Journal
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Figure 10: (a) Dose-response curve and calibration curve (inset) for TC in milk. % B/B0 = −27.7674 × log [TC] − 101.8244, R2 = 0.9823.
(b) Correlation diagram of B/B0 for TC both in buﬀer and in milk. % B/B0 (in milk) = 0.9252 × % B/B0 (in buﬀer) + 8.4232, R2 = 0.9837.
3.2. RNA Aptamer (57 Mer) Assay. Monovalent cations such
as Li+,N a +,a n dK + and divalent ion, Mg2+, have been used
in aptamer assays to stabilize the conformation of aptamer.
In the case of thrombin aptasensor studies, it is mentioned
that an addition of Na+ or K+ can stabilize G-quadruplex
structure and reduce nonspeciﬁc binding. On the other side,
thesemonovalentionscancausetheconformationalchanges
of aptamer binding site and produce a lower aﬃnity to its
target.
In order to study whether monovalent and divalent
cations aﬀect the TC/RNA aptamer binding sensitivity, the
assay buﬀer with and without monovalent and divalent
cations were tried and the results compared. Figure 6(a)
showstheinﬂuenceoftheadditionofNa+ ioninassa ybuﬀer.
As shown in Figure 6(a), the maximum signal absorbance
obtained with 10mM phosphate buﬀer was compared with
that obtained with 10mM phosphate buﬀered saline, PBS
buﬀer. In the case of absence of Na+ ion in the buﬀer
solution, the dose-response curve showed that the signal
gap was suﬃciently large to detect the concentration of TC
distinctly and with a lower detection limit than the one with
Na+ cation.Figure 6(b)showstheinﬂuenceoftheadditionof
Mg2+ ion in the assay buﬀer. Three diﬀerent concentrations
of Mg2+ ion were examined (0.0mM, 2.5mM, and 5.0mM).
As shown in Figure 6(b), the higher concentration of Mg2+
ion was used, the lower the signal gap was obtained. Several
reports using UV-Vis spectroscopy [22] suggested that Mg2+
ion essentially binds to TC. This means that the TC forms
the coordination complex with Mg2+ ion. Thus, Mg2+ ion
can interfere with the binding reaction between TC and RNA
aptamer. Incubation temperature was also studied for ELAA
performance (RT and 4◦C), and it showed no signiﬁcant
diﬀerence on both assay temperatures (Figure 6(c)).
Table 2:RecoverystudyforthedeterminationofTCspikedinmilk.
Spiked conc. of
TC (mgL−1)
Measured conc.
(mgL−1) Recovery (%)
DNA aptamer
9.60 9.119 95.0
2.40 2.390 99.6
0.48 0.463 96.5
RNA aptamer
0.25 0.246 105.9
0.10 0.104 104.7
0.05 0.545 109.1
The concentration of RNA aptamer was optimized
for the assay. Figure 7 shows the binder dilution curve
obtained with four diﬀerent RNA aptamer concentrations
(0.1μgmL −1,0.07μgmL −1,0.05μgmL −1,and0.02μgmL −1)
and the concentration of TC-HRP conjugate (1.0μgmL −1).
As shown in Figure 7, the best detection limit and signal
gap were obtained using a combination of 0.07μgmL −1 of
aptamer and 1.0μgmL −1 of TC-HRP.
Figure 8 shows the dose-response curve constructed with
the optimized conditions using 0.07μgmL −1 (3.7 × 10−9 M)
of RNA aptamer and 1.0μgmL −1 (1.5 × 10−8 M) of TC-HRP
conjugate in the assay buﬀer. The LOD of 2.10 × 10−8M
(10.1μgmL −1)andthedynamicrangeoffrom3.16 ×10−4 M
to3.16 ×10−8 Mwereobtained.Thecalibrationcurve(inset)
was constructed on a dynamic range, and these data gave the
following relationship:
%
B
B0
=− 23.1788 ×log [TC]
−75.2471,

R2 = 0.9851

.
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Table 3: Analytical data for TC aptamer assay (ELAA) compared with TC antibody assay (ELISA).
Method Matrix LOD Dynamic range Linearity, R2
ELAA (DNA) Buﬀer 3.27 × 10−8 M1 . 9 9 × 10−7 M∼1.00 × 10−4 M 0.9934
Milk 9.52 × 10−8 M3 . 1 6 × 10−7 M∼3.16 × 10−4 M 0.9881
ELAA (RNA) Buﬀer 2.10 × 10−8 M3 . 1 6 × 10−8 M∼3.16 × 10−4 M 0.9850
Milk 3.51 × 10−8 M1 . 0 × 10−7 M∼1.0 × 10−4 M 0.9823
ELISA
Buﬀer [21]1 . 7 4 × 10−10 M1 . 0 × 10−9 M∼1.0 × 10−6M 0.9901
Milk [21]1 . 0 × 10−10 M3 . 1 6 × 10−10 M∼3.16 × 10−7 M 0.9862
Honey [22]3 . 9 8 × 10−10 M3 . 1 6 × 10−9 M∼3.16 × 10−7 M 0.9800
The speciﬁcity of the RNA aptamer was evaluated by
cross-reactivity study. Cross-reactivity studies were carried
out by a same method as previous DNA aptamer assay. The
50% B/B0 value and cross-reactivity for each compound are
given in Figure 9 and Table 1. These three cross-reactants
demonstrated similar cross-reactivity (35.3%, 35.3%, and
30.4%) with relatively high value. It supports that the
binding ofTC to RNA aptamer is by hydrophobic or stacking
interaction of the ﬂat polycyclic aromatic ring in TC. Thus,
RNA aptamer gives low speciﬁcity of the binder as compared
to the TC antibody assay [21].
Figure 10(a) shows the dose-response curve and calibra-
tion curve for TC in milk. The LOD and the dynamic range
were 3.51 × 10−8 M (16.8μgmL −1) and from 1.00 × 10−4 M
to 1.00 × 10−7 M, respectively:
%
B
B0
=− 27.7674 ×log [TC]
−101.8244,

R2 = 0.9823

.
(5)
Figure 10(b) shows the correlation diagram of the
absorbance obtained both in buﬀer and in milk:
%
B
B0
(in milk) = 0.9252 ×%
B
B0
(in buﬀer)
+8 .4232,

R2 = 0.9837

.
(6)
The recovery study was performed using commercial milk
purchasedfromlocalmarket againstDNAaptamerandRNA
aptamer,respectively.FreeTCwasspikedinmilksample,and
mean percent recoveries were analyzed. The recovery study
was performed in ten replicates, and the results were quite
satisfactory as seen in Table 2.
4. Conclusion
A competitive ELAA method to detect TC in milk was devel-
oped. The optimization of assay buﬀer including aptamer
aﬀects the sensitivity of the aptamer for the TC. Best results
were obtained without monovalent ion, Na+, and also by
adding no Mg2+ ion in the assay buﬀer, along with RT
incubation.Inthecaseofbothmonovalentanddivalentions,
increased ionic strength resulted in a decreased sensitivity
of the aptamer to TC. This may be explained with shielding
eﬀect of Na+ ion causing the conformational changes of the
aptamer binding site, therefore producing a lower aﬃnity to
itstarget,TC.Additionally,aptamerrecognizestheMg2+ ions
that essentially coordinate TC.
The optimized ELAA method showed a good sensitivity
(LOD of 2.10 × 10−8 M) with a wide dynamic range (3.16
× 10−8 M∼3.16 × 10−4 M). In addition, the average R.S.D.
across all data points of the curve was less than 2.5% with
good recoveries (∼101.8%) from the milk media. Thus,
this method provides a good tool to monitor TC in milk
from MRLs’ point of view. As shown in Tables 1 and 3,
the analytical data from this ELAA method is compared
with those reported previously by ELISA method [21, 22].
However, this ELAA method (DNA or RNA aptamer) was
not superior to the ELISA method (antibody as a binder)
in terms of speciﬁcity, detection limit (LOD), and dynamic
range. It demonstrated that the aﬃnity and speciﬁcity of
these aptamer assays were not advantageous compared to
the previous immunoassay that uses antibodies. This means
that it does not always give better sensitivity and speciﬁcity
in assays even though aptamers have several advantages
over antibodies and have been known to be good binders
for binding assays. This study is the ﬁrst report that uses
validated ELAA for the determination of TC in milk.
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